Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening

Oncogene
A M StroheckerE White

Abstract

Deregulation of autophagy has been linked to multiple degenerative diseases and cancer, thus the identification of novel autophagy regulators for potential therapeutic intervention is important. To meet this need, we developed a high content image-based short hairpin RNA screen monitoring levels of the autophagy substrate p62/SQSTM1. We identified 186 genes whose loss caused p62 accumulation indicative of autophagy blockade, and 67 genes whose loss enhanced p62 elimination indicative of autophagy stimulation. One putative autophagy stimulator, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), drives flux through pentose phosphate pathway. Knockdown of PFKFB4 in prostate cancer cells increased p62 and reactive oxygen species (ROS), but surprisingly increased autophagic flux. Addition of the ROS scavenger N-acetyl cysteine prevented p62 accumulation in PFKFB4-depleted cells, suggesting that the upregulation of p62 and autophagy was a response to oxidative stress caused by PFKFB4 elimination. Thus, PFKFB4 suppresses oxidative stress and p62 accumulation, without which autophagy is stimulated likely as a ROS detoxification response.

References

Feb 13, 2001·Trends in Biochemical Sciences·D A OkarA J Lange
May 13, 2004·Journal of Cell Science·Maximiliano G GutierrezMaría I Colombo
Sep 2, 2004·Journal of Cell Science·Stefanie JägerEeva-Liisa Eskelinen
Mar 7, 2006·Cell Metabolism·Angelina RodriguezJorge Moscat
Jul 15, 2006·Cell·Karim BensaadKaren H Vousden
Jan 20, 2007·The Journal of Clinical Investigation·Ravi K AmaravadiCraig B Thompson
Jan 25, 2007·Molecular Cell·Maria Høyer-HansenMarja Jäättelä
May 9, 2007·Nature Chemical Biology·Sovan SarkarDavid C Rubinsztein
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Jun 28, 2007·The Journal of Biological Chemistry·Edmond Y W ChanSharon A Tooze
Jul 4, 2007·Genes & Development·Vassiliki Karantza-WadsworthEileen White
Jul 13, 2007·Biochemical and Biophysical Research Communications·Keiichi TamaiKazuo Sugamura
Aug 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Masaaki KomatsuZhenyu Yue
Nov 2, 2007·Nature Reviews. Cancer·Robin MathewEileen White
Dec 22, 2007·The Journal of Clinical Investigation·Kirsteen H MacleanMichael B Kastan
Apr 9, 2008·Nature Chemical Biology·Andrea WilliamsDavid C Rubinsztein
Oct 8, 2008·The Journal of Cell Biology·Michael DegtyarevKui Lin
Dec 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Biao LuoDavid E Root
May 2, 2009·Cell Death and Differentiation·Y ChenS B Gibson
May 21, 2009·Experimental and Molecular Pathology·Abdullah YalcinJason Chesney
Jun 11, 2009·Molecular Cancer Therapeutics·Bao HoangAlan Lichtenstein
Jun 16, 2009·Cell·Robin MathewEileen White
Jun 19, 2009·Journal of Cell Science·Tor Erik Rusten, Harald Stenmark
Aug 4, 2009·The Journal of Biological Chemistry·Mala ShanmugamSteven T Rosen
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eileen White, Robert S DiPaola
Aug 29, 2009·The EMBO Journal·Karim BensaadKaren H Vousden
Dec 1, 2009·Cell Metabolism·Eva MasieroMarco Sandri
Dec 5, 2009·The EMBO Journal·Alfredo CriolloGuido Kroemer
Feb 11, 2010·Cell·Noboru MizushimaBeth Levine

❮ Previous
Next ❯

Citations

Mar 20, 2020·PLoS Genetics·Simon HaeusslerBarbara Conradt
Apr 28, 2020·EMBO Reports·Andrea MartelloAndrea Caporali
Feb 6, 2017·Oncotarget·Charlotte TaylorAhmed Ashour Ahmed
May 29, 2020·BioMed Research International·Ran DuanXiaolu Huang
Aug 29, 2019·Frontiers in Molecular Neuroscience·Wenjuan ZhouLiang Kong
Sep 21, 2018·Frontiers in Oncology·Ramon BartronsUbaldo E Martinez-Outschoorn
Apr 6, 2019·Frontiers in Cell and Developmental Biology·Prashanta Kumar PandaSovan Sarkar
Jul 24, 2020·Scientific Reports·Lennart KoepkeKonstantin M J Sparrer
Dec 7, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qiongyao WangLinlang Guo
Jan 1, 2021·Cancer Management and Research·Ying ChuJie Ma
Aug 26, 2020·Trends in Biochemical Sciences·Noboru Mizushima, Leon O Murphy
Aug 28, 2021·International Journal of Molecular Sciences·Sonia E TrojanKinga A Kocemba-Pilarczyk

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPases
GTPase
fluorescence microscopy
flow cytometry
transfection
Flow
flow-cytometry

Software Mentioned

Gene
PANTHER
Cellomics

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.